[ET Net News Agency, 24 November 2022] CSPC PHARMA (01093) rose 2.93% to HK$9.85.
It hits an intra-day high of HK$9.86, and an intra-day low of HK$9.6. The total shares
traded was 14.4 million, with a value of HK$140.24m. The active buy/sell ratio is 58:42,
with net buying turnover of HK$22.51m. CHINA INV INFO accounts for greatest net responsive
buying turnover of HK$4.35m, with volume weighted average price of HK$9.736. CHINA INT'L
CAPITAL CORP HK accounts for greatest net responsive selling turnover of HK$17.18m, with
volume weighted average price of HK$9.768. The stock has risen a combined 3.14% over the
past 2 consecutive trading days.
The Hang Seng Index now rose 82 points, or 0.47% to 17,606; the Hang Seng China
Enterprises Index now rose 28 points, or 0.48% to 5,973; the Hang Seng TECH Index now rose
23 points, or 0.65% to 3,578; with an overall turnover of HK$49.7b.
The SSE Composite Index now fell 3 points, or 0.11% to 3,093, with an overall turnover
of RMB193.77b.
The SZSE Component Index now fell 2 points, or 0.02% to 10,970, with an overall turnover
of RMB100.97b.
Basic Information
=================
---------------------------------
Nominal 9.850 % Chg +2.93%
High 9.860 Low 9.600
Shares Tr 14.4m Turnover 140.24m
10-D SMA 9.865 %H.V 78.155
20-D SMA 9.505 VWAP 9.742
50-D SMA 8.463 RSI14 59.096
---------------------------------
Status: Active buy/sell ratio is 58:42, with net buying turnover of HK$22.51m, rising a
combined 3.14% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSPC PHARMA (01093) 9.85 +2.93
TRAD CHI MED (00570) 3.81 +3.25
SINO BIOPHARM (01177) 4.32 +3.10
3SBIO (01530) 7.95 +0.13
LUYE PHARMA (02186) 2.94 +0.68
FOSUN PHARMA (02196) 24.35 +1.04
WUXI APPTEC (02359) 78.00 +0.97
CHINARES PHARMA (03320) 6.37 +2.74
HANSOH PHARMA (03692) 14.22 +0.57
PHARMARON (03759) 42.50 +0.83
-----------------------------------------------
(ed)